Year |
Citation |
Score |
2022 |
Lilly JV, Rokita JL, Mason JL, Patton T, Stefankiewiz S, Higgins D, Trooskin G, Larouci CA, Arya K, Appert E, Heath AP, Zhu Y, Brown MA, Zhang B, Farrow BK, ... ... Boucher K, et al. The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. Neoplasia (New York, N.Y.). 35: 100846. PMID 36335802 DOI: 10.1016/j.neo.2022.100846 |
0.454 |
|
2017 |
Jain P, Silva A, Han HJ, Lang SS, Zhu Y, Boucher K, Smith TE, Vakil A, Diviney P, Choudhari N, Raman P, Busch CM, Delaney T, Yang X, Olow AK, et al. Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways. Oncotarget. 8: 84697-84713. PMID 29156677 DOI: 10.18632/Oncotarget.20949 |
0.559 |
|
2016 |
Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R, Schumacher SE, Urbanski L, O'Rourke R, Gibson WJ, Pelton K, Ramkissoon SH, Han HJ, Zhu Y, Choudhari N, ... ... Boucher K, et al. MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nature Genetics. PMID 26829751 DOI: 10.1038/Ng.3500 |
0.512 |
|
2016 |
Han H, Baubet V, Boucher K, Pignolo R, Kaplan F, Shore E, Storm P, Dahmane N, Resnick A. HG-59ACVR1-MUTANT DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGs) ACQUIRE ABERRANT ACTIVIN-MEDIATED BMP PATHWAY ACTIVATION Neuro-Oncology. 18: iii61.2-iii61. DOI: 10.1093/Neuonc/Now073.55 |
0.473 |
|
2015 |
Jain P, Fierst T, Silva A, Budlow J, Boucher K, Han H, Storm PB, Waanders A, Resnick AC. Abstract A138: Targeting activated CRAF fusions in pediatric low-grade gliomas Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-A138 |
0.498 |
|
2015 |
Waanders A, Silva A, Chen S, Han H, Zhu Y, Boucher K, Jain P, Fierst T, Choudhari N, Mueller S, Haas-Kogan D, Storm P, Resnick A. TR-06 * COMBINATORIAL PATHWAY TARGETING APPROACHES FOR BRAF-FUSIONS ASSOCIATED WITH PEDIATRIC LOW-GRADE GLIOMAS Neuro-Oncology. 17: iii37-iii38. DOI: 10.1093/Neuonc/Nov061.151 |
0.566 |
|
2013 |
Sievert AJ, Lang SS, Boucher KL, Madsen PJ, Slaunwhite E, Choudhari N, Kellet M, Storm PB, Resnick AC. Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas. Proceedings of the National Academy of Sciences of the United States of America. 110: 5957-62. PMID 23533272 DOI: 10.1073/Pnas.1219232110 |
0.541 |
|
2012 |
Lang S, Sievert AJ, Boucher KL, Madsen PJ, Slaunwhite E, Brewington D, Storm PB, Resnick AC. 193 Development of Pediatric Glioma Models for BRAF-targeted Therapy Neurosurgery. 71: E575. DOI: 10.1227/01.neu.0000417783.83750.a5 |
0.469 |
|
2012 |
Brognaro E, Ghods A, Feinstein D, Glick R, Connolly KJ, Meetze K, Boudrow A, Gyuris J, Han M, Hingtgen S, Figueiredo J, Farrar C, Farrar C, Deubgen M, Martinez-Quintanilla J, ... ... Boucher K, et al. LAB-TUMOR MODELS (IN VIVO/IN VITRO) Neuro-Oncology. 14: vi160-vi164. DOI: 10.1093/Neuonc/Nos241 |
0.486 |
|
2011 |
Maag D, Maxwell MJ, Hardesty DA, Boucher KL, Choudhari N, Hanno AG, Ma JF, Snowman AS, Pietropaoli JW, Xu R, Storm PB, Saiardi A, Snyder SH, Resnick AC. Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB. Proceedings of the National Academy of Sciences of the United States of America. 108: 1391-6. PMID 21220345 DOI: 10.1073/Pnas.1017831108 |
0.45 |
|
Show low-probability matches. |